Literature DB >> 14764531

Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development.

Li Xue1, Xiaoyong Chen, Yanjie Chang, James J Bieker.   

Abstract

Erythroid Krüppel-like factor (EKLF) plays an essential role in enabling beta-globin expression during erythroid ontogeny. It is first expressed in the extraembryonic mesoderm of the yolk sac within the morphologically unique cells that give rise to the blood islands, and then later within the hepatic primordia. The BMP4/Smad pathway plays a critical role in the induction of EKLF, and transient transfection analyses demonstrate that sequences located within less than 1 kb of its transcription initiation site are sufficient for high-level erythroid-specific transcription. We have used transgenic analyses to verify that 950 bp located adjacent to the EKLF start site of transcription is sufficient to generate lacZ expression within the blood islands as well as the fetal liver during embryonic development. Of particular importance are 3 regions, 2 of which overlap endogenous erythroid-specific DNase hypersensitive sites, and 1 of which includes the proximal promoter region. The onset of transgene expression mimics that of endogenous EKLF as it begins by day 7.5 (d7.5) to d8.0. In addition, it exhibits a strict hematopoietic specificity, localized only to these cells and not to the adjacent vasculature at all stages examined. Finally, expression is heterocellular, implying that although these elements are sufficient for tissue-specific expression, they do not shield against the position effects of adjacent chromatin. These analyses demonstrate that a surprisingly small DNA segment contains all the information needed to target a linked gene to the hematopoietic compartment at both early and later stages of development, and may be a useful cassette for this purpose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764531     DOI: 10.1182/blood-2003-09-3231

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.

Authors:  Dewang Zhou; Kaimao Liu; Chiao-Wang Sun; Kevin M Pawlik; Tim M Townes
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

2.  Lineage-specific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors.

Authors:  Stefania Bottardi; Julie Ross; Natacha Pierre-Charles; Volker Blank; Eric Milot
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

3.  Altered regulation of beta-like globin genes by a redesigned erythroid transcription factor.

Authors:  Deepa Manwani; Mariann Galdass; James J Bieker
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

4.  Single cell transcriptomics reveals unanticipated features of early hematopoietic precursors.

Authors:  Jennifer Yang; Yoshiaki Tanaka; Montrell Seay; Zhen Li; Jiaqi Jin; Lana Xia Garmire; Xun Zhu; Ashley Taylor; Weidong Li; Ghia Euskirchen; Stephanie Halene; Yuval Kluger; Michael P Snyder; In-Hyun Park; Xinghua Pan; Sherman Morton Weissman
Journal:  Nucleic Acids Res       Date:  2017-02-17       Impact factor: 16.971

5.  Extrinsic and intrinsic control by EKLF (KLF1) within a specialized erythroid niche.

Authors:  Li Xue; Mariann Galdass; Merlin Nithya Gnanapragasam; Deepa Manwani; James J Bieker
Journal:  Development       Date:  2014-06       Impact factor: 6.868

6.  Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.

Authors:  E Delabesse; S Ogilvy; M A Chapman; S G Piltz; B Gottgens; A R Green
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 7.  Mammalian Krüppel-like factors in health and diseases.

Authors:  Beth B McConnell; Vincent W Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 8.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

9.  The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells.

Authors:  Felix Lohmann; Mohan Dangeti; Shefali Soni; Xiaoyong Chen; Antanas Planutis; Margaret H Baron; Kyunghee Choi; James J Bieker
Journal:  Mol Cell Biol       Date:  2015-08-24       Impact factor: 4.272

Review 10.  An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.

Authors:  Gerd A Blobel; David Bodine; Marjorie Brand; John Crispino; Marella F T R de Bruijn; David Nathan; Thalia Papayannopoulou; Catherine Porcher; John Strouboulis; Len Zon; Douglas R Higgs; George Stamatoyannopoulos; James Douglas Engel
Journal:  Exp Hematol       Date:  2015-07-02       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.